Category Archives: Ligand

The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?

Author: James W. Fawcett Abstract: Axon regeneration in the CNS is inhibited by many extrinsic and intrinsic factors. Because these act in parallel, no single intervention has been sufficient to enable full regeneration of damaged axons in the adult mammalian … Continue reading

Posted in Chronic Spinal Cord Injury Research, Gene Therapy, Ligand, spinal cord injury research, Stem Cell Research | Tagged

NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING

Vancouver, Canada. March 13, 2019 – NervGen Pharma Corp. (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, today announced that it has completed its initial public offering (“IPO”) of … Continue reading

Posted in Ligand, Regenerative Medicine, spinal cord injury research | Tagged , ,

Dr Jerry Silver – Spinal Cord Damage and Emerging Treatments

“Injuries to the spinal cord can cause permanent paralysis and even lead to death, with little to no hope of regaining lost functions once the trauma has occurred. Dr Jerry Silver and his team at Case Western Reserve University Medical … Continue reading

Posted in Chronic Spinal Cord Injury Research, Ligand, Regenerative Medicine, spinal cord injury research | Tagged , ,